7emz
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='7emz' size='340' side='right'caption='[[7emz]], [[Resolution|resolution]] 2.30Å' scene=''> | <StructureSection load='7emz' size='340' side='right'caption='[[7emz]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[7emz]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[7emz]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Aspergillus_novofumigatus_IBT_16806 Aspergillus novofumigatus IBT 16806]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7EMZ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7EMZ FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=FE:FE+(III)+ION'>FE</scene>, <scene name='pdbligand=H3X:methyl+(3~{a}~{R},4~{S},5~{S},5~{a}~{S},6~{S},7~{S},9~{a}~{R})-1,1,3~{a},4,5~{a},7,7-heptamethyl-3,6-bis(oxidanylidene)spiro[4,5,7,8,9,9~{a}-hexahydrobenzo[c]oxepine-6,2-4,5-dihydro-3~{H}-1-benzofuran]-5-carboxylate'>H3X</scene>, <scene name='pdbligand=OGA:N-OXALYLGLYCINE'>OGA</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> |
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=FE:FE+(III)+ION'>FE</scene>, <scene name='pdbligand=H3X:methyl+(3~{a}~{R},4~{S},5~{S},5~{a}~{S},6~{S},7~{S},9~{a}~{R})-1,1,3~{a},4,5~{a},7,7-heptamethyl-3,6-bis(oxidanylidene)spiro[4,5,7,8,9,9~{a}-hexahydrobenzo[c]oxepine-6,2-4,5-dihydro-3~{H}-1-benzofuran]-5-carboxylate'>H3X</scene>, <scene name='pdbligand=OGA:N-OXALYLGLYCINE'>OGA</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7emz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7emz OCA], [https://pdbe.org/7emz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7emz RCSB], [https://www.ebi.ac.uk/pdbsum/7emz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7emz ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7emz FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7emz OCA], [https://pdbe.org/7emz PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7emz RCSB], [https://www.ebi.ac.uk/pdbsum/7emz PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7emz ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/NVFI_ASPN1 NVFI_ASPN1] Fe(II)/2-oxoglutarate-dependent dioxygenase; part of the gene cluster that mediates the biosynthesis of novofumigatonin, a heavily oxygenated meroterpenoid containing a unique orthoester moiety (PubMed:29968715). The first step of the pathway is the synthesis of 3,5-dimethylorsellinic acid (DMOA) by the polyketide synthase nvfA via condensation of one acetyl-CoA starter unit with 3 malonyl-CoA units and 2 methylations (PubMed:29968715). DMOA is then converted to farnesyl-DMOA by the farnesyltransferase nvfB (PubMed:29968715). Epoxydation by FAD-dependent monooxygenase nvfK, followed by a protonation-initiated cyclization catalyzed by the terpene cyclase nvfL leads to the production of asnavolin H (PubMed:29968715). The short chain dehydrogenase nvfC then as a 3-OH dehydrogenase of asnovolin H to yield chemesin D (PubMed:29968715). There are two branches to synthesize asnovolin A from chemesin D (PubMed:29968715). In one branch, chemesin D undergoes Baeyer-Villiger oxidation by nvfH, methylation by nvfJ, and enoyl reduction by the nvfM D enoylreductase that reduces the double bond between C-5'and C-6', to form respectively asnovolin I, asnovolin K, and asnovolin A (PubMed:29968715). In the other branch, the methylation precedes the Baeyer-Villiger oxidation and the enoyl reduction to yield asnovolin A via the asnovolin J intermediate (PubMed:29968715). Asnovolin A is further converted to fumigatonoid A by the Fe(II)/2-oxoglutarate-dependent dioxygenase nvfI that catalyzes an endoperoxidation reaction (PubMed:29968715). The alpha/beta hydrolase nvfD then acts as an epimerase that converts fumigatonoid A to its C-5' epimer, which then undergoes spontaneous or nvfD-catalyzed lactonization (PubMed:29968715). The following step utilizes the ketoreductase nvfG to produce fumigatonoid B (PubMed:29968715). The dioxygenase nvfE further converts fumigatonoid B into fumigatonoid C (PubMed:29968715). Finally the Fe(II)/2-oxoglutarate-dependent dioxygenase nvfF catalyzes two rounds of oxidation to transform fumigatonoid C into the end product, novofumigatonin A (PubMed:29968715).<ref>PMID:29968715</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 20: | Line 23: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Aspergillus novofumigatus IBT 16806]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Abe | + | [[Category: Abe I]] |
- | [[Category: Mori | + | [[Category: Mori T]] |
- | + | ||
- | + | ||
- | + |
Revision as of 16:56, 29 November 2023
iron and alpha-ketoglutarate-dependent endoperoxidase NvfI W199F variant
|